Breaking News Instant updates and real-time market news.

CW

Curtiss-Wright

$134.96

-2.27 (-1.65%)

16:16
12/02/19
12/02
16:16
12/02/19
16:16

Curtiss-Wright announces $50M share repurchase program

Curtiss-Wright announced that its board of directors has authorized the company to repurchase $50M of shares via a 10b5-1 program beginning in January 2020, which is expected to more than offset potential dilution from compensation plans. The company has $200M available under the current share repurchase authorization, $50M of which will be allocated to the 10b5-1 program mentioned above and $100M of which will be available to repurchase additional shares opportunistically through a supplemental 10b5-1 program.

CW Curtiss-Wright
$134.96

-2.27 (-1.65%)

12/19/18
STFL
12/19/18
UPGRADE
Target $122
STFL
Buy
Curtiss-Wright upgraded to Buy from Hold at Stifel
Stifel analyst Nathan Jones upgraded Curtiss-Wright to Buy and raised his price target to $122 from $120, saying the stock should benefit from a more defensive investor positioning in 2019 and also believes that its 26% sell-off since mid-September peak is overdone. The analyst notes that as part of his expectation of slower 2019 growth, he prefers companies with "strong balance sheets to both protect and provide flexibility to pick off quality assets should a downturn materialize." Jones also sees Curtiss-Wright benefiting from the increase in the Department of Defense budget as well as the cyclically positive position of its power business.
01/07/19
WBLR
01/07/19
NO CHANGE
WBLR
Outperform
Curtiss-Wright remains top multi-industry pick for 2019 at William Blair
William Blair analyst Nicholas Heymann says Curtiss-Wright remains his multi-industry top pick to outperform in 2019. The analyst attributes the 28% selloff in the stock since mid-September to heightened fears regarding a potential decline in the company's "highly lucrative" China sales starting in 2020 and of possibly slower growth in the U.S. Department of Defense procurement budget for fiscal 2020. However, the anticipated downturn in Curtiss-Wright's China Direct reactor coolant pump sales in 2020 is likely to be largely mitigated by "strong growth" in the company's other nuclear component and service sales to the Department of Defense for upcoming new aircraft carriers and submarine programs, Heymann tells investors in a research note. He expects greater clarity surrounding the company's nuclear components and service and defense business for 2019 and 2020 is forthcoming with the Q4 earnings report. Heymann keeps an Outperform rating on Curtiss-Wright.
03/01/19
BOFA
03/01/19
DOWNGRADE
BOFA
Neutral
Curtiss-Wright downgraded to Neutral from Buy at BofA/Merrill
03/01/19
03/01/19
DOWNGRADE
Target $135

Neutral
Curtiss-Wright downgraded to Neutral on valuation, growth at BofA/Merrill
As previously reported, BofA/Merrill downgraded Curtiss-Wright to Neutral from Buy and maintained a $135 price target. Analyst Kristine Liwag said Curtiss-Wright's full year 2018 organic growth of 3% and 2019 sales growth of 3-5% are disappointing and notes shares are trading above historical valuation.

TODAY'S FREE FLY STORIES

GOLD

Barrick Gold

$16.85

-0.045 (-0.27%)

07:41
12/10/19
12/10
07:41
12/10/19
07:41
Hot Stocks
Barrick Gold to sell 90% interest in Massawa project to Teranga for up to $430M »

Barrick Gold announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$62.68

-1.77 (-2.75%)

07:41
12/10/19
12/10
07:41
12/10/19
07:41
Hot Stocks
Sage Therapeutics announces planned progression of SAGE-718 »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RH

RH

$237.33

-4.62 (-1.91%)

07:40
12/10/19
12/10
07:40
12/10/19
07:40
Recommendations
RH analyst commentary  »

RH price target raised to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WCC

Wesco

$54.92

-0.32 (-0.58%)

, AXE

Anixter

$88.88

-0.18 (-0.20%)

07:39
12/10/19
12/10
07:39
12/10/19
07:39
Upgrade
Wesco, Anixter rating change  »

Wesco upgraded to Strong…

WCC

Wesco

$54.92

-0.32 (-0.58%)

AXE

Anixter

$88.88

-0.18 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

NFLX

Netflix

$302.48

-4.88 (-1.59%)

07:39
12/10/19
12/10
07:39
12/10/19
07:39
Conference/Events
Netflix management to meet with UBS »

Dinner Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

SGEN

Seattle Genetics

$114.26

-3.26 (-2.77%)

07:38
12/10/19
12/10
07:38
12/10/19
07:38
Initiation
Seattle Genetics initiated  »

Seattle Genetics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

SYBT

S.Y. Bancorp

$41.02

-0.03 (-0.07%)

07:38
12/10/19
12/10
07:38
12/10/19
07:38
Conference/Events
S.Y. Bancorp management to meet with Stephens »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

DG

Dollar General

$154.81

0.075 (0.05%)

07:37
12/10/19
12/10
07:37
12/10/19
07:37
Hot Stocks
Dollar General announces availability of CBD products in select states »

Dollar General announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HROW

Harrow Health

$6.53

0.04 (0.62%)

07:37
12/10/19
12/10
07:37
12/10/19
07:37
Hot Stocks
Harrow Health subsidiary announces outsourcing facility ships to California »

ImprimisRx, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TENB

Tenable Holdings

$24.81

-0.46 (-1.82%)

07:36
12/10/19
12/10
07:36
12/10/19
07:36
Recommendations
Tenable Holdings analyst commentary  »

Tenable Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

TROW

T. Rowe Price

$124.48

0.59 (0.48%)

07:35
12/10/19
12/10
07:35
12/10/19
07:35
Hot Stocks
T. Rowe Price reports preliminary AUM $1.18T at November 30 »

Client transfers from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

FTSV

Forty Seven

$30.44

16.04 (111.39%)

07:35
12/10/19
12/10
07:35
12/10/19
07:35
Recommendations
Forty Seven analyst commentary  »

Forty Seven price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZS

Zscaler

$47.34

0.62 (1.33%)

, TPR

Tapestry

$25.80

0.26 (1.02%)

07:35
12/10/19
12/10
07:35
12/10/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

ZS

Zscaler

$47.34

0.62 (1.33%)

TPR

Tapestry

$25.80

0.26 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 16

    Dec

  • 10

    Jan

FRAN

Francesca's

$19.83

1.29 (6.96%)

07:34
12/10/19
12/10
07:34
12/10/19
07:34
Earnings
Francesca's reports Q3 adj. EPS ($1.12) vs. ($2.08) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

WH

Wyndham Hotels & Resorts

$57.94

-0.1 (-0.17%)

07:34
12/10/19
12/10
07:34
12/10/19
07:34
Conference/Events
Wyndham Hotels & Resorts management to meet with Wolfe Research »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CNST

Constellation Pharmaceuticals

$36.15

-7.95 (-18.03%)

07:33
12/10/19
12/10
07:33
12/10/19
07:33
Recommendations
Constellation Pharmaceuticals analyst commentary  »

Constellation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

AMGN

Amgen

$232.74

-1 (-0.43%)

07:33
12/10/19
12/10
07:33
12/10/19
07:33
Hot Stocks
Amgen says Phase 3 CANDOR study met primary endpoint »

Amgen announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$17.10

-0.59 (-3.34%)

, BMRN

BioMarin

$78.87

-1.03 (-1.29%)

07:32
12/10/19
12/10
07:32
12/10/19
07:32
Hot Stocks
Invitae launches Discover Dysplasias initiative with BioMarin »

Invitae (NVTA) announced…

NVTA

Invitae

$17.10

-0.59 (-3.34%)

BMRN

BioMarin

$78.87

-1.03 (-1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATI

Allegheny Technologies

$23.76

0.1 (0.42%)

, GE

General Electric

$10.99

-0.105 (-0.95%)

07:32
12/10/19
12/10
07:32
12/10/19
07:32
Hot Stocks
Allegheny Technologies extends long-term purchase agreements with GE Aviation »

Allegheny Technologies…

ATI

Allegheny Technologies

$23.76

0.1 (0.42%)

GE

General Electric

$10.99

-0.105 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 29

    Jan

PTON

Peloton

$34.78

2.215 (6.80%)

07:31
12/10/19
12/10
07:31
12/10/19
07:31
Recommendations
Peloton analyst commentary  »

Peloton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VVV

Valvoline

$22.21

-0.17 (-0.76%)

07:31
12/10/19
12/10
07:31
12/10/19
07:31
Conference/Events
Valvoline management to meet with Buckingham »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

PCG

PG&E

$11.05

1.4 (14.51%)

07:30
12/10/19
12/10
07:30
12/10/19
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

LEG

Leggett & Platt

$52.17

-0.91 (-1.71%)

07:29
12/10/19
12/10
07:29
12/10/19
07:29
Downgrade
Leggett & Platt rating change  »

Leggett & Platt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADUS

Addus HomeCare

$93.83

-1.6 (-1.68%)

07:29
12/10/19
12/10
07:29
12/10/19
07:29
Recommendations
Addus HomeCare analyst commentary  »

Addus HomeCare price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VGR

Vector Group

$12.74

-0.66 (-4.93%)

07:29
12/10/19
12/10
07:29
12/10/19
07:29
Conference/Events
Vector Group management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.